Study Summary
To evaluate the tolerability and safety of CAR-T technology in patients with relapsed or refractory hematolymphoid malignancies.
Want to learn more about this trial?
Request More InfoInterventions
CAR-T Autologous T cell injectionBIOLOGICAL
Biological: CAR-T; Drug: Cyclophosphamide,Fludarabine；Procedure: Leukapheresis
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Shanxi Bethune Hospital | Taiyuan | Shanxi | China |